These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7790 related items for PubMed ID: 2513378

  • 1. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
    Trotta PP, Harrison SD.
    Cancer Res; 1987 Oct 15; 47(20):5347-53. PubMed ID: 3115565
    [Abstract] [Full Text] [Related]

  • 3. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
    Huang P, Allam A, Perez LA, Taghian A, Freeman J, Suit HD.
    Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):93-8. PubMed ID: 7721643
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
    Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ, Shepard HM.
    Cancer Res; 1987 Oct 15; 47(20):5382-5. PubMed ID: 2820567
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
    Malik ST, Knowles RG, East N, Lando D, Stamp G, Balkwill FR.
    Cancer Res; 1991 Dec 15; 51(24):6643-9. PubMed ID: 1742738
    [Abstract] [Full Text] [Related]

  • 15. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug 15; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
    Murray JL, Zukiwski AA, Mujoo K, Rosenblum MG.
    J Biol Response Mod; 1990 Dec 15; 9(6):556-63. PubMed ID: 2074442
    [Abstract] [Full Text] [Related]

  • 18. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L, Xiao M, Wu B, Wang WX, Yan WR, Broxmeyer HE, Shen RN.
    Int J Hematol; 1993 Oct 15; 58(3):139-52. PubMed ID: 8148492
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L.
    Stem Cells; 1993 Sep 15; 11(5):412-21. PubMed ID: 8241952
    [Abstract] [Full Text] [Related]

  • 20. VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha.
    Renard N, Nooijen PT, Schalkwijk L, De Waal RM, Eggermont AM, Liénard D, Kroon BB, Lejeune FJ, Ruiter DJ.
    J Pathol; 1995 Jul 15; 176(3):279-87. PubMed ID: 7674090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 390.